13F
中

IART INTEGRA LIFESCIENCES HOLDING

2026Q1 · CUSIP 457985208 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
200
Δ holders QoQ
-8
Breadth percentile
Top 83%
Whale holders
117
Δ whales
+5
Inst. holding value
$701M
New positions
33
Closed positions
41
Price momentum (1Q)
+23.3%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+16 · h=235 2018Q2: Δ+20 · h=255 2018Q3: Δ-8 · h=247 2018Q4: Δ+1 · h=248 2019Q1: Δ+11 · h=259 2019Q2: Δ+4 · h=263 2019Q3: Δ+19 · h=282 2019Q4: Δ-2 · h=280 2020Q1: Δ-21 · h=259 2020Q2: Δ+4 · h=263 2020Q3: Δ-26 · h=237 2020Q4: Δ+15 · h=252 2021Q1: Δ+4 · h=256 2021Q2: Δ+9 · h=265 2021Q3: Δ-3 · h=262 2021Q4: Δ+15 · h=277 2022Q1: Δ+1 · h=278 2022Q2: Δ+3 · h=281 2022Q3: Δ+1 · h=282 2022Q4: Δ+0 · h=282 2023Q1: Δ-2 · h=280 2023Q2: Δ+2 · h=282 2023Q3: Δ-21 · h=261 2023Q4: Δ+24 · h=285 2024Q1: Δ-6 · h=279 2024Q2: Δ-40 · h=239 2024Q3: Δ-14 · h=225 2024Q4: Δ-1 · h=224 2025Q1: Δ-2 · h=222 2025Q2: Δ-11 · h=211 2025Q3: Δ-2 · h=209 2025Q4: Δ-1 · h=208 2026Q1: Δ-8 · h=200 2018Q1: holders=235 2018Q2: holders=255 2018Q3: holders=247 2018Q4: holders=248 2019Q1: holders=259 2019Q2: holders=263 2019Q3: holders=282 2019Q4: holders=280 2020Q1: holders=259 2020Q2: holders=263 2020Q3: holders=237 2020Q4: holders=252 2021Q1: holders=256 2021Q2: holders=265 2021Q3: holders=262 2021Q4: holders=277 2022Q1: holders=278 2022Q2: holders=281 2022Q3: holders=282 2022Q4: holders=282 2023Q1: holders=280 2023Q2: holders=282 2023Q3: holders=261 2023Q4: holders=285 2024Q1: holders=279 2024Q2: holders=239 2024Q3: holders=225 2024Q4: holders=224 2025Q1: holders=222 2025Q2: holders=211 2025Q3: holders=209 2025Q4: holders=208 2026Q1: holders=200 -40 -20 +0 +20 +40 180240300 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2019Q3 Top 9% +4.3% -14.6%
2018Q2 Top 11% -11.8% -14.1%
2018Q1 Top 13% -7.0% -18.1%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-6.47
EPS YoY
—
Revenue (TTM)
$1.6B
Revenue YoY
+1.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $398M 2022-09-30: $385M 2022-12-31: $398M 2023-03-31: $381M 2023-06-30: $381M 2023-09-30: $382M 2023-12-31: $397M 2024-03-31: $369M 2024-06-30: $418M 2024-09-30: $381M 2024-12-31: $443M 2025-03-31: $383M 2025-06-30: $416M 2025-09-30: $402M 2025-12-31: $435M 2026-03-31: $392M 2022-06-30: EPS 0.54 2022-09-30: EPS 0.60 2022-12-31: EPS 0.63 2023-03-31: EPS 0.29 2023-06-30: EPS 0.05 2023-09-30: EPS 0.24 2023-12-31: EPS 0.26 2024-03-31: EPS -0.04 2024-06-30: EPS -0.16 2024-09-30: EPS -0.14 2024-12-31: EPS 0.25 2025-03-31: EPS -0.33 2025-06-30: EPS -6.31 2025-09-30: EPS -0.07 2025-12-31: EPS -0.03 2026-03-31: EPS -0.06 0M 221M 443M $M -6.94 -3.12 0.69 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 54 2023-03-31: PE 24.12023-06-30: PE 27.52023-09-30: PE 32.32023-12-31: PE 53.62024-03-31: PE 542024-06-30: PE 71.9 22 49 75 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)